WellBound Stockton — Stockton, California

WellBound Stockton is a clinical research site located in Stockton, California, United States 95219.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

WellBound Stockton has participated in 2 clinical trials.

Therapeutic areas: Renal Dialysis, Kidney Failure, Chronic, Fluid Overload Pulmonary Edema.

Sponsors: Satellite Healthcare.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stockton

Browse all research sites in California · View every site in Stockton

• San Joaquin General Hospital
• University of the Pacific
• University of Pacific
• Dameron Hospital
• Kaiser Permanente-Stockton
• Saint Joseph's Medical Center
• Research Site
• Kaiser Permanente Medical Facility - Stockton
• Bensch Research Associates
• Novartis Investigative Site
• GSK Investigational Site
• St Joseph's Medical Center

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for WellBound Stockton?

WellBound Stockton has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has WellBound Stockton conducted?

WellBound Stockton has 2 clinical trials on record. Their work covers Renal Dialysis, Kidney Failure, Chronic, Fluid Overload Pulmonary Edema.

Is WellBound Stockton accredited by Crixeo Clinical Trials?

WellBound Stockton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about WellBound Stockton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.